Chakraborti Sajal, Mandal Malay, Das Sudip, Mandal Amritlal, Chakraborti Tapati
Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India.
Mol Cell Biochem. 2003 Nov;253(1-2):269-85. doi: 10.1023/a:1026028303196.
Matrix metalloproteinases (MMPs) are a major group of enzymes that regulate cell-matrix composition. MMP genes show a highly conserved modular structure. Ample evidence exists on the role of MMPs in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, cardiovascular diseases, pulmonary diseases and cancer. The expression patterns of MMPs have interesting implications for the use of MMP inhibitors as therapeutic agents. Insights might be gained as to the preference for a general MMP inhibitor as opposed to an inhibitor designed to be specific for certain MMP family members as it relates to a defined disease state, and may give clues to potential side effects. The signalling pathways that lead to induction of expression of MMPs are still incompletely understood, but certain patterns are beginning to emerge. Regarding inhibition of MMP expression at the level of kinase pathways, it is possible that selective chemical inhibitors for distinct signalling pathways (e.g. MAPK, PKC) will hopefully, soon be available for initial clinical trials. Overexpression of selective dual specificity MAPK phosphatases have been shown to prevent MMP promoter activation which could also be used as a novel strategy to prevent activation of AP-1 and ETS transcription factors and MMP promoters in vivo. Interactions between members of different transcription factors provide fine-tuning of the transcriptional regulation of MMP promoter activity. MMPs play a crucial role in tumor invasion. Although the expression of MMPs in malignancies has been studied widely, the specific role of distinct MMPs in the progression of cancer may be more complex than has been assumed. For example, it has recently been shown that MMP-3, MMP-7, MMP-9 and MMP-12 can generate angiostatin from plasminogen, indicating that their expression in peritumoral area may in fact serve to limit angiogenesis and thereby inhibit tumor growth and invasion. The recent view about the role of stromal cells in the progression of cancer cell growth and metastasis is particularly interesting, and additional studies about the regulation of MMP gene expression and activity in malignancies are needed to understand the role and regulation of MMPs in tumor cell invasion.
基质金属蛋白酶(MMPs)是调节细胞-基质组成的主要酶类。MMP基因呈现高度保守的模块化结构。有充分证据表明MMPs在正常和病理过程中发挥作用,包括胚胎发育、伤口愈合、炎症、关节炎、心血管疾病、肺部疾病和癌症。MMPs的表达模式对于将MMP抑制剂用作治疗药物具有有趣的启示。对于使用通用MMP抑制剂而非针对特定MMP家族成员设计的抑制剂(与特定疾病状态相关)的偏好可能会获得一些见解,并且可能提示潜在的副作用。导致MMPs表达诱导的信号通路仍未完全理解,但某些模式已开始显现。关于在激酶途径水平抑制MMP表达,有望很快获得用于初始临床试验的针对不同信号通路(如MAPK、PKC)的选择性化学抑制剂。选择性双特异性MAPK磷酸酶的过表达已被证明可防止MMP启动子激活,这也可作为一种新策略在体内防止AP-1和ETS转录因子及MMP启动子的激活。不同转录因子成员之间的相互作用对MMP启动子活性的转录调控进行微调。MMPs在肿瘤侵袭中起关键作用。尽管MMPs在恶性肿瘤中的表达已得到广泛研究,但不同MMPs在癌症进展中的具体作用可能比之前设想的更为复杂。例如,最近研究表明MMP-3、MMP-7、MMP-9和MMP-12可从纤溶酶原生成血管抑素,这表明它们在肿瘤周边区域的表达实际上可能有助于限制血管生成,从而抑制肿瘤生长和侵袭。关于基质细胞在癌细胞生长和转移进展中的作用的最新观点特别有趣,需要对恶性肿瘤中MMP基因表达和活性的调控进行更多研究,以了解MMPs在肿瘤细胞侵袭中的作用和调控。